May. 13 at 2:51 AM
$GUTS As of May 2026, H.C. Wainwright maintains a "Buy" rating on Fractyl Health (GUTS) with a price target of
$8.00. Analysts remain bullish on the clinical-stage metabolic company, despite recent share price volatility, with the target suggesting significant upside from its current price in the range